Oral cancer drugs have become significantly more expensive compared with those from 15 years ago, according to a new study. The research provides insight into rising drug prices in the U.S., particularly among specialty medications.
Oral cancer drugs have become significantly more expensive compared with those from 15 years ago, according to a new study. The research provides insight into rising drug prices in the U.S., particularly among specialty medications.
Share this Article
Recommended